Home › Funds › Kynam Capital Management, LP › ENGN

Kynam Capital Management, LP position in ENGN

ENGENE THERAPEUTICS INC · Health Care

Kynam Capital Management, LP reported holding 457,855 shares of ENGN (ENGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$792K, representing 0.04% of its reported portfolio and ranking #31 among its reported holdings. Kynam Capital Management, LP has disclosed ENGN holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)457.86K sh
Reported value held$792.09K
Portfolio Weight0.04%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Kynam Capital Management, LP's ENGN position evolved

Kynam Capital Management, LP first disclosed a stake in ENGN in Q3 2024 at 1,736,227 shares (US$11.5M). The position peaked in Q3 2025 at 4,994,090 shares, worth US$34.1M. Across 8 filings, Kynam Capital Management, LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 457,855 shares valued at US$792K — a reduction of -898,988 shares quarter over quarter.. Notable position changes include a 188% increase in Q4 2024 (shares fell 33% over the following quarter), a 70% trim in Q4 2025 (shares fell 25% over the following quarter), a 66% trim in Q2 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.74M $11.46M New
Q4 2024 4.99M $33.21M Add
Q1 2025 4.99M $22.37M Hold
Q2 2025 4.99M $18.18M Hold
Q3 2025 4.99M $34.11M Hold
Q4 2025 1.49M $13.48M Reduce
Q1 2026 1.36M $9.24M Reduce
Q2 2026 457.86K $792.09K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ENGN and 13F data

ENGN (ENGENE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in ENGN — the largest reported positions include FCPM III SERVICES B.V. (US$16.7M), BML Capital Management, LLC (US$11.5M), Nextech Invest Ltd. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENGN

All ENGN fund holders →

FAQ

How long has Kynam Capital Management, LP held ENGN?

Kynam Capital Management, LP has disclosed ENGN holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Kynam Capital Management, LP's current position in ENGN?

As of Q2 2026, Kynam Capital Management, LP holds 457.86K shares of ENGN (ENGENE THERAPEUTICS INC), valued at $792.09K, representing 0.04% of its reported portfolio and ranking #31.

Has Kynam Capital Management, LP been buying or selling ENGN?

In the latest 13F filing (Q2 2026), Kynam Capital Management, LP reduced its position in ENGN. The position peaked in Q3 2025 at 4.99M shares.

Which other funds hold ENGN?

Other major institutional holders of ENGN include FCPM III SERVICES B.V., BML Capital Management, LLC, Nextech Invest Ltd., among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.